Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

317.03 USD +13.05 (+4.29%)
Official Closing Price Updated: 4:36 PM EST, Nov 27, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Illumina Inc

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
ILMN January 2021 Options Begin Trading
Investors in Illumina Inc (ILMN) saw new options become available today, for the January 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ILMN options chain... 
Tags Stocks
From Market News Video
TalkMarkets Tuesday Talk: Optimism Advancing On Turkeys
Boosted by the the AstraZeneca vaccine news US markets closed higher on Monday. Encouraged by the GSA release of Presidential transition funds post-close, Tuesday market futures are trading higher. 
Tags Stocks / Equities Commodities Pharma/Biotech
From Blogs - TalkMarkets
Framing The Macro Scenario For The Post-COVID-19 World
The economic framework is exhibiting some interesting indicators. Unemployment, savings rate, and consumption data seem to corroborate the thesis of a sustained recovery. A new stimulus package and a... 
Tags Stocks / Equities
From Blogs - TalkMarkets
Illumina to Webcast Upcoming Investor Conference Presentation
Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast. 
From Business Wire News Releases
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)
Consortium aims to make comprehensive genomic profiling accessible to advanced cancer patients in the U.S. to inform medical management and improve patient outcomes. 
From PR Newswire
Wild Ride For Illumina Stock Shows Promise, Challenge Of Multi-Cancer Blood Tests
Liquid biopsy technology offers promise of the medical Holy Grail, early detection of multiple cancers. Illumina, Exact Sciences deals heating up a game-changing field in cancer treatment. 
From Investor's Business Daily
Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit
. Illumina, Inc. (NASDAQ: ILMN) is further extending the reach of the NextSeq™ 2000 Sequencing System with the commercial availability of the P3 high-output flow cell. The P3 flow cell offers 1.1... 
From Business Wire News Releases
Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA
Twist Bioscience Corporation (NASDAQ: TWST), Illumina, Inc. (NASDAQ: ILMN) and Western Digital (NASDAQ: WDC) today announced the formation of an alliance with Microsoft to advance the field of DNA data... 
From Business Wire News Releases
Nina Deka: Biotech Stocks To Watch As Covid-19 Vaccines Come Online
Nina Deka, senior research analyst at ROBO Global, joined the podcast this week to discuss trends in the healthcare sector and biotech stocks which stand to benefit from coronavirus vaccine treatments.... 
From Investor's Business Daily
Las Vegas Sands Moves Up In Market Cap Rank, Passing Illumina
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Las Vegas Sands Corp (LVS) has taken over the #143 spot from Illumina Inc (ILMN), according to... 
Tags Stocks
From Market News Video
Notable Wednesday Option Activity: KURA, SRG, ILMN
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Kura Oncology Inc (KURA), where a total volume of 3,394 contracts has been traded... 
Tags Stocks
From Market News Video
Illumina: Q3 Earnings Insights
Shares of Illumina (NASDAQ:ILMN) were flat in after-market trading after the company reported Q3 results. Quarterly ... 
Tags Market News ILMN Earnings
From Benzinga
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2020
Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the third quarter of fiscal year 2020. 
From Business Wire News Releases
The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags RPRX CCXI UTHR
From Benzinga
Exact Sciences Rallies On 2 M&A Deals In Cancer Screening Market
Shares of cancer screening and diagnostics company EXACT Sciences Corporation (NASDAQ: EXAS) wererallying to a record high ... 
Tags SVB Leerink Analyst Color Benzinga
From Benzinga
IBB, GILD, ILMN, BIIB: ETF Outflow Alert
Symbols mentioned in this story: IBB, GILD, ILMN, BIIB Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs
Biotech stocks posted weekly declines in the week ended Oct. 23, pressured by the broader market decline amid mixed earnings reports and ... 
Tags VKTX APLT Benzinga
From Benzinga
Should These Top Medical Stocks Be On Your Watchlist? 3 To Watch
From Stockmarket.com
IDbyDNA and Illumina Launch New Rapid Test to Better Detect Respiratory Co-Infections and Identify Antibiotic Resistant Pathogens
New Panel to Provide Support During Onset of Flu Season in the Midst of the COVID-19 Pandemic 
From PR Newswire
S&P 500 Movers: WFC, CXO
In early trading on Wednesday, shares of Concho Resources topped the list of the day's best performing components of the S&P 500 index, trading up 12.2%. Year to date, Concho Resources has lost about... 
Tags Stocks
From Market News Video
Nasdaq 100 Movers: FAST, MRNA
In early trading on Tuesday, shares of Moderna topped the list of the day's best performing components of the Nasdaq 100 index, trading up 4.5%. Year to date, Moderna Inc registers a 302.1% gain. 
Tags Stocks
From Market News Video
Benzinga's Top Upgrades, Downgrades For October 13, 2020
Upgrades Benchmark upgraded the previous rating for Owens-Corning Inc (NYSE: OC) from Hold to Buy. In the second quarter, ... 
Tags CG AWK Upgrades
From Benzinga
Next Coronavirus Market Correction: Where to Invest $5,000
When you have an opportunity to buy the best stocks on the cheap, don't outsmart yourself. 
Tags Market News ISRG TIF
From Motley Fool
Why Ilumina's Stock Fell 13.5% in September
The gene sequencing giant needs to show that its acquisition of Grail can translate into meaningful business growth. 
Tags Market News ILMN
From Motley Fool
Here are the biggest winners in a solid third quarter for U.S. stocks
Gains were spread across tech, materials, industrials and retailers. 
Tags DOW KO COP
From MarketWatch
Benzinga's Top Upgrades, Downgrades For September 30, 2020
Upgrades For Alarm.com Holdings Inc (NASDAQ: ALRM), Roth Capital upgraded the previous rating of Neutral to the current rating ... 
Tags NBIX ATHM HOME
From Benzinga
Better Buy: Invitae vs. Illumina
Which stock wins in this genetics version of David versus Goliath? 
Tags ILMN Market News NVTA
From Motley Fool
Is Exact Sciences a Good Healthcare Stock to Buy Now?
The company known for Cologuard is trying to cast a much wider net. 
Tags Market News EXAS ILMN
From Motley Fool
Cramer Shares His Thoughts On Boeing, General Electric And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said to a viewerhe is right to buy Boeing Co (NYSE: BA). He likes ... 
Tags AAL Media BA
From Benzinga
Illumina to Announce Third Quarter 2020 Financial Results on Thursday, October 29, 2020
Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the third quarter 2020 following the close of market on Thursday, October 29, 2020. 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.